Migraine Management, Volume 196 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine is explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents is presented, along with an evidence-based review of pharmacologic management. This includes recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable, are also critically reviewed.
Finally, specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly are covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness is also explored.
- Summarizes evidence-based best treatment for migraines
- Differentiates treatment based on patient population, migraine type, and clinical setting
- Includes pharmacological, biobehavioral, and physical treatments
- Provides specialized treatments for children, the elderly, and pregnant patients
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science & Techn.
Dateigröße
ISBN-13
978-0-12-823481-5 (9780128234815)
Schweitzer Klassifikation
Section I. Migraine Management1. Non-specific analgesics, combination analgesics, and antiemetics2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans3. 5-HT1F agonists4. CGRP receptor antagonists (Gepants)5. Preventive treatment of migraine: Non-specific oral agents6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention8. Nutraceuticals in migraine9. Interventional treatments10. Biobehavioral treatments of migraine11. Physical treatment of migraine12. Neuromodulation in migraineSection II. Guidelines13. Evidence-based symptomatic treatment of migraine14. Evidence-based preventive treatment of migraineSection III. Special Cases/Situations15. Treatment in the emergency department16. Special considerations in migraine during pregnancy and lactation17. Special considerations in management of migraine in the elderly18. Management of medication overuse headacheSection IV. Outcome Measures19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatmentSection V. Diagnosis and Treatment of Other Migraine Subtypes20. Menstrually associated migraine21. Hemiplegic migraine22. Migraine with brainstem aura23. Retinal migraine24. Vestibular migraine and persistent postural perceptual dizziness25. Status migrainosus26. Persistent aura, visual snow, and other visual symptoms27. Migrainous infarction28. Migraine in children and adolescents: Assessment and diagnosis 29. Management of migraine in children and adolescentsSection VI. Comorbidities of Migraine30. Psychiatric comorbidities of migraine31. Relationship of migraine and other forms of chronic pain32. Comorbidities of migraine: Sleep disorders33. The evolving concept of multimorbidity and migraineSection VII. Future Directions34. Healthcare disparities faced by patients with migraine and potential mitigation strategies35. Emerging and future directions of migraine research and treatment
